It is a pharma private limited company based in Ankleshwar, Gujarat, India, established in 2021.
2021 | Ankleshwar, Gujarat, India | ActiveAxaj Pharmaceuticals Private Limited, a active private limited company, was established on 05 October 2021 in Ankleshwar, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2021PTC126115. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹6.00 M.
It upholds a compliant status. Its leadership includes Dhavalkumar Vitthalbhai Patel (Director), Krushnakumar Ghanshyambhai Darji (Director), Sarojbahen Vasantlal Patel (Director). Past directors included Mohit Kumar Pareek. It holds ₹3.43 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/298/2/7 Saykha Gidc Estate,, Ankleshwar, Gujarat, 392140.
U24230GJ2021PTC126115
126115
05 October 2021
₹6.00 M
₹6.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Axaj Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhavalkumar Vitthalbhai Patel | Director | 05 Oct 2021 | Current |
| Krushnakumar Ghanshyambhai Darji | Director | 05 Oct 2021 | Current |
| Sarojbahen Vasantlal Patel | Director | 05 Oct 2021 | Current |
| Majulaben Vithalbhai Patel | Director | 08 Sep 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Axaj Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 38.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 70.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Axaj Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹34,348,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2023 | Others | ₹3.43 Cr | Open |
Explore comprehensive loan charge details -
Axaj Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Axaj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axaj Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Axaj Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Axaj Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
A charge with Others amounted to Rs. 34.35 M with Charge ID 100707061 was registered on 21 Mar 2023. was recorded as a recent event.
Majulaben Vithalbhai Patel was appointed as a Director was appointed as a Director on 08 Sep 2022 & has been associated with this company since 3 years 3 months . was recorded as a recent event.
The activity Dhavalkumar Vitthalbhai Patel was appointed as a Director was appointed as a Director on 05 Oct 2021 & has been associated with this company since 4 years 2 months . was completed.
Progress on Krushnakumar Ghanshyambhai Darji was appointed as a Director was appointed as a Director on 05 Oct 2021 & has been associated with this company since 4 years 2 months . was documented.
The CIN of Axaj Pharmaceuticals Private Limited is U24230GJ2021PTC126115.
Axaj Pharmaceuticals Private Limited is headquartered at C/298/2/7 Saykha Gidc Estate,, Ankleshwar, Gujarat, 392140.
Axaj Pharmaceuticals Private Limited was incorporated on 05 October 2021.
The current directors of Axaj Pharmaceuticals Private Limited are
The primary industry of Axaj Pharmaceuticals Private Limited is Manufacturing.
Axaj Pharmaceuticals Private Limited is unlisted.
The authorized capital of Axaj Pharmaceuticals Private Limited is ₹6.00 M, and the paid-up capital is ₹6.00 M.
The compliance status of Axaj Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX